Study on Tear Proteins in Diabetic Retinopathy of Type 2 Diabetics
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00698698|
Recruitment Status : Unknown
Verified January 2009 by Dow University of Health Sciences.
Recruitment status was: Active, not recruiting
First Posted : June 17, 2008
Last Update Posted : February 2, 2009
|Condition or disease|
Diabetes mellitus causes a significant alteration in tear proteins. If we analyze tear proteins by means of electrophoresis, HPLC, and mass spectroscopy.
We can find different type of tear proteins in different grades of diabetic retinopathy these biomarkers can help in mass screening , diagnosis and management of diabetic population.
|Study Type :||Observational|
|Estimated Enrollment :||350 participants|
|Official Title:||Tear Proteins and Diabetic Retinopathy|
|Study Start Date :||January 2009|
|Estimated Primary Completion Date :||December 2010|
|Estimated Study Completion Date :||June 2011|
Normal age and sex matched population
Diabetic population with no retinopathy or Mild non proliferative diabetic retinopathy
Moderate non proliferative diabetic retinopathy
Severe non proliferative diabetic retinopathy
Proliferative diabetic retinopathy and advanced diabetic eye disease
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00698698
|Dow University of Health Sciences|
|Karachi, Sindh, Pakistan, 75500|
|Principal Investigator:||Dr. Jamshed Ahmed, FCPS||Dow University of Health Sciences Pakistan|